Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | FAAH | O00519 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | DGKA | P23743 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL6948482 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL6948245 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Heptane SCHEMBL1591796 | 0.98 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL7315287 | 0.98 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL6415173 | 0.98 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL3003669 | 0.98 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL8820866 | 0.96 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Ethyl Acetate SCHEMBL6986234 | 0.95 | ALDH1A1 (0.67) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Heptane SCHEMBL2706852 | 0.94 | ALDH1A1 (0.58) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL10002813 | 0.93 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116621882-A | Platinum-based bowl phosphine complex, fullerene array thereof, preparation and application thereof | 广西师范大学 | 2023-08-22 | — | — | CN | claimed |
| CN-110396116-B | [ N, O ] bidentate nickel and palladium complex of ketone-imidazoline-2-imine ligand, and preparation method and application thereof | 东华大学 | 2020-07-28 | — | — | CN | claimed |
| CN-110396116-A | Ketone-imidazoline -2- imine ligand [N, O] bidentate nickel, palladium complex and the preparation method and application thereof | UNIV NATIONAL DONG HWA | 2019-11-01 | — | — | CN | claimed |
| CN-113166140-B | CDK8/19 inhibitors | 拜奥卡德联合股份公司 | 2024-06-14 | — | — | CN | disclosed |
| US-20240182463-A1 | SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG | SHIONOGI & CO., LTD. (JP) | 2024-06-06 | — | — | US | disclosed |
| US-20240166689-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-05-23 | — | — | US | disclosed |
| US-20240148699-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2024-05-09 | — | — | US | disclosed |
| US-RE49918-E1 | Cytotoxic benzodiazepine derivatives | IMMUNOGEN, INC. (US) | 2024-04-16 | — | — | US | disclosed |
| WO-2024075696-A1 | IMIDAZOPYRIDINE DERIVATIVES WITH BICYCLIC STRUCTURE | 公立大学法人横浜市立大学 | 2024-04-11 | — | — | WO | disclosed |
| US-11891457-B2 | Peptide-compound cyclization method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-02-06 | — | — | US | disclosed |
| WO-2024024700-A1 | LIQUID CRYSTAL COMPOSITION, OPTICAL ANISOTROPIC FILM, NEAR INFRARED RAY-ABSORBING DYE | ＡＧＣ株式会社 | 2024-02-01 | — | — | WO | disclosed |
| US-4575555-A | ANTIDEPRESSANTS | MEAD JOHNSON & COMPANY (US) | 1986-03-11 | — | — | US | disclosed |
| EP-0146243-A1 | Lipoxygenase inhibitors | MERCK FROSST CANADA INC. (CA) | 1985-06-26 | — | — | EP | disclosed |
| US-4524212-A | HYPOTENSIVE AGENTS, ANGIOTENSIN INHIBITORS | E. R. SQUIBB & SONS, INC. (US) | 1985-06-18 | — | — | US | disclosed |
| US-4481144-A | 17-Substituted thia-17-alkyl(or alkenyl or alkynyl)androstenes | E. R. SQUIBB & SONS, INC. (US) | 1984-11-06 | — | — | US | disclosed |
| US-4434098-A | PYRYLIUM DYE SENSITIZERS | EASTMAN KODAK COMPANY (US) | 1984-02-28 | — | — | US | disclosed |
| US-4427586-A | ANTI-BACTERIAL AGENTS AND ENZYME INHIBITORS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1984-01-24 | — | — | US | disclosed |
| EP-0052299-A1 | 2-Oxoazetidine derivatives and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1982-05-26 | — | — | EP | disclosed |
| US-4075351-A | INHIBITION OF MALE FERTILITY WITH ALIPHATIC SULFAMATES | ORTHO PHARMACEUTICAL CORPORATION (US) | 1978-02-21 | — | — | US | disclosed |
| US-3997585-A | Aliphatic sulfamates | ORTHO PHARMACEUTICAL CORPORATION (US) | 1976-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11891457-B2 | Peptide-compound cyclization method | VIP, NGLY1, GLP1R | ALDH1A1 4857/4885LMNA 2193/4885HSD17B10 3115/4885 |
| US-20240182463-A1 | SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG | PREP, UNG, DPP4 | ALDH1A1 1564/4885LMNA 1238/4885HSD17B10 1241/4885 |
| US-20240148699-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | PDE3B, PDE4A, PDE3A | ALDH1A1 234/4885LMNA 3948/4885HSD17B10 552/4885 |
| US-20240166689-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | VIP, NGLY1, GLP1R | ALDH1A1 4857/4885LMNA 2193/4885HSD17B10 3115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.